During the past decade, Hattiesburg Clinic - Hematology/Oncology Clinic conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 27 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 18 clinical trials were completed. i.e. 163.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hattiesburg Clinic - Hematology/Oncology Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Incyte Corporation" with 4 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hattiesburg Clinic - Hematology/Oncology Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Hattiesburg Clinic - Hematology/Oncology Clinic" are "Breast Cancer" (6 trials), "Lymphoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Hattiesburg Clinic - Hematology/Oncology Clinic" in a lesser frequency.

Most popular intervention types in "Hattiesburg Clinic - Hematology/Oncology Clinic" are "Drug" (48 trials), "Other" (27 trials), "Biological" (20 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Cisplatin" (8 trials), "Placebo" (8 trials), "Nivolumab" (6 trials) and "Quality-of-Life Assessment" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hattiesburg Clinic - Hematology/Oncology Clinic" are 49 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Hattiesburg Clinic - Hematology/Oncology Clinic". undefined are not yet recruiting, 11 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Hattiesburg Clinic - Hematology/Oncology Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hattiesburg Clinic - Hematology/Oncology Clinic, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".